Image

    Nail Loss After Teriflunomide Treatment: A New Potential Adverse Event

    Luca Mancinelli, Paolo Amerio, Maria di Ioia … Alessandra Lugaresi
    Studysummary This study suggests that nail loss may be a new, reversible adverse event related to teriflunomide treatment, akin to its known effects on hair loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on msard-journal.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Proposing a Simpler Classification of Telogen Effluvium Skin appendage disorders · 2016
    2. Pooled Safety and Tolerability Data from Four Placebo-Controlled Teriflunomide Studies and Extensions Multiple Sclerosis and Related Disorders · 2015
    3. Teriflunomide and Its Mechanism of Action in Multiple Sclerosis Drugs · 2014
    4. Hair and Nail Relationship: A Comparative Study Skinmed · 2005

    Related research 2

    1. Nail Loss After Teriflunomide Treatment: A New Potential Adverse Event Multiple Sclerosis and Related Disorders · 2017
    2. Pooled Safety and Tolerability Data from Four Placebo-Controlled Teriflunomide Studies and Extensions Multiple Sclerosis and Related Disorders · 2015